Pooled safety analysis from phase I-III studies for patients with hematological malignancies treated with the PI3K inhibitor copanlisib Meeting Abstract
| Authors: | Zinzani, P. L.; Özcan, M.; Capra, M.; Santoro, A.; Panayiotidis, P.; Bouabdallah, K.; Jurczak, W.; Phelps, C.; Hiemeyer, F. J. R.; Soler, L. M.; Garcia-Vargas, J.; Childs, B. H.; Lenz, G.; Matasar, M. J.; Dreyling, M. |
| Abstract Title: | Pooled safety analysis from phase I-III studies for patients with hematological malignancies treated with the PI3K inhibitor copanlisib |
| Meeting Title: | 64th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 140 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2022 Dec 10-13 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2022-11-15 |
| Start Page: | 6470 |
| End Page: | 6473 |
| Language: | English |
| ACCESSION: | WOS:000893223206218 |
| DOI: | 10.1182/blood-2022-167368 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
